View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 21, 2020updated 02 Mar 2021 5:41pm

Coronavirus: US scientists work on vaccine; WHO to determine severity

Scientists at the National Institutes of Health (NIH) in the US have already started working towards a vaccine against the new, deadly coronavirus that emerged in China last month and so far has claimed six lives.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Follow the latest updates of the outbreak on our timeline.

Scientists at the National Institutes of Health (NIH) in the US have already started working towards a vaccine against the new, deadly coronavirus that emerged in China last month and so far has claimed six lives, with the death toll expected to rise further.

Meanwhile, the World Health Organization (WHO) has called for a meeting on 22 January to assess the severity of the outbreak and determine whether it is an international health emergency.

Coronavirus cases

The coronavirus is related to the family of Severe Acute Respiratory Syndrome (SARS) virus, which caused an outbreak two decades ago and killed several people. Coronavirus has started spreading from animals to humans and is capable of human-to-human transmission.

Initially reported in Wuhan, the coronavirus has now infected nearly 300 people and is spreading to more Chinese cities and other countries.

Coronavirus vaccine

National Institutes of Allergy and Infectious Diseases (NIAID) director Dr Anthony Fauci has said that the NIH is developing a vaccine for the virus, reported CNN.

However, it would take months for the vaccine to advance into clinical trials and more than one year until it is available.

A team of scientists in Texas, New York and China are also working on a vaccine, noted Baylor College of Medicine vaccine scientist Dr. Peter Hotez. After a vaccine is available, health care workers are likely to receive it first as they are exposed to infected patients.

According to a CBC report, Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan in Canada has requested to work on the virus to potentially develop a vaccine.

Separately, US-based biotechnology company Moderna has annouced that it is collaborating with NIH, NIAID and Vaccine Research Center (VRC) to develop a vaccine.

In its SEC filing, the company said: “Moderna’s mRNA vaccine technology could serve as a rapid and flexible platform that may be useful in responding to newly emerging viral threats, such as the novel coronavirus.

“While we have not previously tested this rapid response capability, Moderna confirms that we are working with NIH/NIAID/VRC on a potential vaccine response to the current public health emergency.”

Travel restrictions against coronavirus outbreak

Although official travel restrictions have not been put in place, screening is being conducted at airports in China, Hong Kong, Thailand, Russia and the US.

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU